Compare Moderna, Inc. (MRNA) vs NICE Ltd (NICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs NICE Ltd — how do they compare? Moderna, Inc. trades at $60.73 (market cap $24.18B), while NICE Ltd trades at $99.78 (market cap $6.02B). The key difference: Moderna, Inc. is far larger — about 4× NICE Ltd's market cap, and Moderna, Inc. is trading nearer its 52-week high, NICE Ltd nearer its low. Which is the better fit depends on your goals.
| MRNA | NICE | |
|---|---|---|
Market Cap | $24.18B | $6.02B |
Sector | Health | Technology |
52-Week High | $81.80 | $153.44 |
52-Week Low | $22.36 | $83.15 |
Enterprise Value | $20.33B | $5.75B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →
